Skip to main content

Kodiak Sciences Inc.

For the period ended Dec 31, 2024. Filed Mar 27, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 27, 2025

KOD$107.10+7.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Balance Sheets

December 31,2024December 31,2023
Assets
Current assets:
Cash and cash equivalents$168,074$285,507
Prepaid expenses and other current assets3,8623,802
Total current assets171,936289,309
Restricted cash6,1846,324
Property and equipment, net102,222120,482
Operating lease right-of-use asset46,50854,541
Other assets8,7288,716
Total assets$335,578$479,372
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable$3,915$13,608
Accrued and other current liabilities11,03018,351
Operating lease liability10,6289,770
Total current liabilities25,57341,729
Operating lease liability, net of current portion59,71771,862
Liability related to sale of future royalties100,000100,000
Total liabilities185,290213,591
Commitments and contingencies (Note 8)
Stockholders’ equity:
Preferred stock, $0.0001 par value, 10,000,000 shares authorized; 0 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively——
Common stock, $0.0001 par value, 490,000,000 shares authorized at December 31, 2024 and December 31, 2023; 52,726,916 and 52,508,602 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively55
Additional paid-in capital1,479,0211,418,307
Accumulated deficit(1,328,738)(1,152,531)
Total stockholders’ equity150,288265,781
Total liabilities and stockholders’ equity$335,578$479,372
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.